Flora Growth Corp. (FLGC) Financials
FLGC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 31.6 million | 18.5 million |
2023-06-30 | 30.5 million | 20.3 million |
2023-03-31 | 77.0 million | 23.4 million |
2022-12-31 | 81.0 million | 24.6 million |
FLGC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 512000 | 4000 |
2023-06-30 | -3.6 million | 338000 |
2023-03-31 | -4.4 million | 654000 |
2022-12-31 | -2.4 million | 220000 |
FLGC Net Income
No data available :(
FLGC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 4.8 million | - | 2.0 million |
2023-06-30 | 1.8 million | - | 2.2 million |
2023-03-31 | 5.3 million | - | 2.9 million |
2022-12-31 | 9.5 million | - | 3.1 million |
FLGC Shares Outstanding
FLGC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 6000 | 8000 | 3.4 million | 1.1 million |
2023-06-30 | 93000 | 13000 | 5.7 million | 1.3 million |
2023-03-31 | 102000 | 16000 | 5.6 million | 1.3 million |
2022-12-31 | 346000 | 162000 | 6.9 million | 1.5 million |
FLGC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 17.3 million | 12.4 million |
2023-06-30 | 21.5 million | 17.5 million |
2023-03-31 | 20.1 million | 14.6 million |
2022-12-31 | 11.5 million | 8.6 million |
FLGC
Price: $1.62
52 week price:
Earnings Per Share: -6.34 USD
P/E Ratio: -0.09
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 2.7 million
Market Capitalization: 21.4 million